BRIEF-Bristol-Myers Squibb signs exclusive agreement with Bavarian Nordic for PROSTVAC

* Bristol-Myers Squibb signs exclusive agreement with Bavarian Nordic for PROSTVAC, a prostate-specific antigen-targeting cancer immunotherapy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.